Akt hyper-phosphorylation at residue S477 could potentially serve as a biomarker for the risk of progression of NAFLD to hepatocellular carcinoma although further investigation is warranted. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.